XML 12 R46.htm IDEA: XBRL DOCUMENT v2.4.0.6
Legal Proceedings (Details) (USD $)
 3 Months Ended 6 Months Ended 3 Months Ended 1 Months Ended
Jul. 03, 2011
Jan. 02, 2011
Jul. 01, 2012
Jan. 02, 2011
Restitution [Member]
Jan. 02, 2011
Average Wholesale Price Litigation [Member]
Civil penalties [Member]
Jul. 03, 2011
Risperdal [Member]
Civil penalties [Member]
Jul. 01, 2012
Levaquin [Member]
claimants
Jul. 01, 2012
ASR [Member]
claimants
Jul. 01, 2012
Pinnacle Acetabular Cup System [Member]
claimants
Jul. 01, 2012
Risperdal [Member]
claimants
Jul. 01, 2012
Pelvic Meshes [Member]
claimants
Jul. 01, 2012
Duragesic [Member]
claimants
Jul. 01, 2012
Topamax [Member]
claimants
Apr. 30, 2012
Risperdal [Member]
Legal Proceeding (Textuals) [Abstract]                            
Product Liability Contingency Number Of Claimants             3,400 7,200 1,700 420 1,400 35 60  
Amount given to plaintiff by jury $ 482,000,000                          
Verdict Against Company 593,000,000   257,700,000                      
Litigation Settlement Pre Judgment Interest 111,000,000                          
Assessed damages for alleged consumer fraud as to DURAGESIC and RISPERDAL   4,500,000                        
Net litigation expense     73,000,000                      
Litigation Loss       45,000,000 6,500,000 327,100,000                
Civil Penalties                           $ 1,200,000,000